Hematopoiesis, the process by which all blood cells are formed, is a tightly regulated process that is disrupted in a number of blood diseases, including leukemias. The main interest of our laboratory is to define the mechanisms that regulate normal and leukemic hematopoiesis. Current projects include the following:
Characterization of the pathogenesis of congenital neutropenia syndromes.
These syndromes are characterized by neutropenia at birth and are associated with a marked propensity to develop leukemia. Studies to define the molecular mechanisms of disease pathogenesis and leukemogenesis are underway.
Identification of the mechanisms regulating the trafficking of neutrophils and hematopoietic stem cells from the bone marrow to blood.
Neutrophils are released from the bone marrow in a regulated fashion to maintain homeostatic levels in the blood and to rapidly increase neutrophil numbers in the blood in response to stress, such as infection. We are characterizing the molecular mechanisms regulating neutrophil and stem cell release from the bone marrow to blood.
Characterization of leukemic stem cells.
A major emphasis in current cancer research is the identification of cancer stem cells and the molecular pathways that mediate their inherent resistance to chemotherapy. We have developed a novel mouse model to study leukemic stem cells. Studies are underway to understand how leukemic stem cells gain clonal dominance in the bone marrow.
|
Regulation of stem cell niches in the bone marrow by G-CSF. Treatment of G-CSF leads to a marked suppression of osteoblasts in the bone marrow, leading to the mobilization of stem cells into the blood. In contrast, the vascular niche appears to be unaffected. |
| 1981 | BS, University of Wisconsin-Milwaukee, Milwaukee, WI |
| 1985 | MD, University of Wisconsin-Madison, Madison, WI |
| 1984 | Medical Research, NCI summer training award, NIH, Baltimore, MD |
| 1985-1986 | Intern in Medicine, Barnes Hospital, St. Louis, MO |
| 1986-1988 | Assistant Resident in Medicine, Barnes Hospital, St. Louis, MO |
| 1988-1992 | Hematology-Oncology Fellow, Washington University Medical Center, St. Louis, MO |
| 1993-1996 | Instructor, Department of Medicine, Washington University Medical School, St. Louis, MO |
| 1996-2003 | Assistant Professor, Departments of Medicine and Pathology & Immunology, Washington University Medical School, St. Louis, MO |
| 2003-2008 | Associate Professor, Department of Medicine, Washington University Medical School, St. Louis, MO |
| 2008-present | Professor, Departments of Medicine and Pathology & Immunology, Washington University Medical School, St. Louis, MO |
| Co-program leader, Hematopoietic Development and Malignancy Program, Siteman Cancer Center | |
| Co-leader, Translational Oncology Program at Washington University | |
| Member, Basic Science Leadership Committee, Siteman Cancer Center | |
| Markey Pathway Admissions and Steering Committee, Washington University | |
| MA/MD Program Admissions and Steering Committee, Washington University | |
| Summer Scholars Program in Biology and Biomedical Research Admissions Committee, Washington University |
| 1989 | Internal Medicines |
| 1990 | Hematology |
| 1981 | Kurt H. Vanselow Undergraduate Research Scholarship; University of Wisconsin-Milwaukee, Milwaukee, WI |
| 1981 | The American Institute of Chemists' Student Award; University of Wisconsin-Milwaukee, Milwaukee, WI |
| 1981 | Phi Beta Kappa; University of Wisconsin-Milwauikee, Milwuakee, WI |
| 1981-1984 | Outstanding Achievement Award by Promotion's Committee; University of Wisconsin-Madison Medical School, Madison, WI |
| 1982 | Academic Excellence Award (top 2% of class); University of Wisconsin-Madison Medical School, Madison, WI |
| 1984 | Alpha Omega Alpha; University of Wisconsin-Madison Medical School, Madison, WI |
| 1984 | NCI Summer Training Award; National Institutes of Health, Bethesda, MD |
| 1993 | McDonnell Scholar in Molecular Oncology; Washington University Medical Center, St. Louis, MO |
| 1998 | 28th Mallinckrodt Scholar, Edward Mallinckrodt, Jr. Foundation |
| 2000 | Election to American Society of Clinical Investigation |
| 2005 | Medical Advisory Board of the Severe Congenital Neutropenia International Registry |
| 2009 | Election to the Association of American Physicians |
| 2002 | Editorial Board, Experimental Hematology |
| 2002 | Editorial Board, Blood |
| Alpha Omega Alpha | |
| American Society of Hematology | |
| American Society of Clinical Investigation | |
| Association of American Physicians | |
| International Society for Experimental Hematology |